XRP Healthcare M&A Holding Inc. is a Dubai-based healthcare acquisition and technology company, focused on AI-powered healthcare initiatives and pharmacy M&A across Africa. This entity is legally and operationally separate from XRP Healthcare LLC, which manages all XRPH token and digital asset activities. XRP Healthcare M&A Holding Inc. does not issue, control, or benefit from the XRPH token. For digital asset information, visit www.xrphtoken.com..
31/07/2025
Going public isn’t just a corporate milestone — it’s a signal of readiness, resilience, and a blueprint built for scale.
At XRP Healthcare, our progress toward a proposed listing on the TSX Venture Exchange (TSXV) is the result of a meticulously planned and executed strategy. With the recent signing of a Definitive Agreement with AAJ Capital 3 Corp. and strategic guidance from ARC Group, we’re entering the final phases of a transformative chapter.
But public listings are about far more than checklists and legal approvals. They reflect operational maturity, market alignment, and a foundation strong enough to support international impact.
Here’s how we’ve structured that foundation to support both our listing goals and our broader mission in modern healthcare.
XRP Healthcare originated in the United Kingdom, and our legal and operational architecture reflects a clear intention: to scale globally while retaining security, control, and clarity.
Our structural pillars include:
Registered trademarks across key regions — including the UK, EU, Uganda, and UAE — to protect brand identity and future market entry.
Legally incorporated entities in Dubai and Uganda, designed for ownership transparency and seamless cross-border operations.
Operational segmentation between pharmacy services, tech platforms, and ecosystem development — all aligned under a singular corporate vision.
This deliberate structure offers not just stability, but agility — enabling us to navigate regulatory environments, defend our IP, and deploy services at speed.
Through the acquisition of Uganda-based Pharma Ville, we now manage a growing network of seven pharmacy locations, which serve as community health anchors within our ecosystem.
Our transformation plan includes:
Rebranding under the XRP Healthcare name beginning Q4 2025
Integrating advanced inventory and customer management systems
Laying the groundwork for new offerings — diagnostics, delivery services, and AI-assisted care
These locations represent more than real estate; they’re strategic health access points that bring intelligent, community-focused care closer to people’s everyday lives.
To complement our on-ground presence, we’ve introduced the XRP Healthcare Prescription Savings Card, an initiative designed to improve access to affordable medication.
Highlights of the program:
Discounts up to 80% on prescriptions
Accepted at over 68,000 U.S. pharmacies, including Walgreens, CVS, and Walmart
Available to patients at no cost
As we expand geographically, this tool will integrate directly with our mobile app — enabling users to find the lowest medication prices nearby, powered by real-time data and AI.
Brand trust in healthcare starts with brand protection. That’s why we’ve secured trademarks in all jurisdictions where we currently operate — and in those we plan to enter.
Trademark coverage includes:
The United Kingdom, our origin and branding base
The European Union, offering protection across 27 countries
Uganda, the center of our pharmacy and AI deployment
The United Arab Emirates, home to XRP Healthcare LLC and a strategic hub for expansion
These protections aren’t just defensive — they’re proactive enablers of long-term growth.
This proposed public listing marks not a shift in direction, but the continuation of a growth strategy years in the making.
If approved, the listing is expected to:
Fuel future acquisitions in East Africa
Accelerate development of our AI health assistant
Enhance partnerships with government and NGO healthcare programs
Broaden access and adoption of our services and retail network
Our goal isn’t to go public for the sake of publicity — it’s to amplify our impact.
With the final steps of the TSXV process underway, our focus remains forward-looking and growth-driven.
Key priorities include:
Scaling pharmacy integration across Uganda and beyond
Adding diagnostic intelligence and real-time price comparisons to our AI assistant
Growing the reach of the Prescription Savings Card through expanded partnerships
Launching into new African markets with operational control and trademark protections in place
We’ve built more than a company — we’ve built an infrastructure for accessible, intelligent healthcare.
To learn more about our journey and next milestones, visit www.xrphealthcare.ai
This article contains forward-looking information under applicable securities laws, including statements about a proposed listing, anticipated business growth, product development, and expansion strategies. Actual outcomes may vary due to a range of risks and uncertainties. Completion of the proposed transaction is subject to approvals from the TSX Venture Exchange and other regulators. XRP Healthcare does not undertake to update forward-looking statements unless legally required.